Last reviewed · How we verify
Pancreatic Enzyme Replacement Therapy
Pancreatic Enzyme Replacement Therapy (PERTh) is a marketed product by Anna Evans Phillips, positioned in the treatment of pancreatic insufficiency. The key composition patent is set to expire in 2028, providing a clear period of exclusivity and potential revenue stability. The primary risk is the lack of disclosed key trial results and revenue data, which may limit investor confidence and market competitiveness.
At a glance
| Generic name | Pancreatic Enzyme Replacement Therapy |
|---|---|
| Also known as | kreon |
| Sponsor | Anna Evans Phillips |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Breath Test-Based Assessment of SIBO in Chronic Pancreatitis and Partial Pancreatectomy
- Pancreatic Enzyme Replacement in Acute Necrotizing Pancreatitis (PHASE3)
- Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC) (PHASE1, PHASE2)
- THE MALABSORPTION BLOOD TEST TRIAL WILL HELP DETERMINE THE BENEFITS OF PANCREATIC ENZYME REPLACEMENT THERAPY IN PATIENTS WITH MILD TO MODERATE EXOCRINE PANCREATIC INSUFFICIENCY. (PHASE4)
- Pancreaze (Pancrelipase) for Patients With Pancreatic Adenocarcinoma With Cachexia and Exocrine Pancreatic Insufficiency (PHASE2)
- Pancreatic Enzyme Replacement Therapy for Acute Pancreatitis-Associated Exocrine Pancreatic Insufficiency (PHASE4)
- PERT in Acute Necrotizing Pancreatitis (PHASE3)
- Efficacy of PERT for PEI in Unresectable Pancreatic Cancer. (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Pancreatic Enzyme Replacement Therapy CI brief — competitive landscape report
- Pancreatic Enzyme Replacement Therapy updates RSS · CI watch RSS
- Anna Evans Phillips portfolio CI